Inactivation of the p53 pathway has been reported in osteosarcoma (Wunder et al, 2005) and this is indeed confirmed when comparing expression profiles from osteosarcoma with its presumed progenitor, MSCs and osteoblasts. The gene discussed is TP53; the disease is osteosarcoma.